References
- BeecherHKThe powerful placeboJ Am Med Assoc1955159171602160613271123
- KaptchukTJPowerful placebo: the dark side of the randomised controlled trialLancet1998351172217259734904
- ErnstEReschKLConcept of true and perceived placebo effectsBMJ19953115515537663213
- ErnstEPlacebo: new insights into an old enigmaDrug Discov Today20071241341817467578
- MoyadMAThe placebo effect and randomized trials: analysis of conventional medicineUrol Clin North Am200229112513312109340
- van LeeuwenJHCastroRBusseMBemelmansBLThe placebo effect in the pharmacologic treatment of patients with lower urinary tract symptomsEur Urol200650344045216753253
- TakeiRIkegakiIShibataKTsujimotoGAsanoTNaftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptorsJpn J Pharmacol19997944745410361884
- IkemotoIKiyotaHOhishiYUsefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover studyInt J Urol2003101158759414633083
- GotohMKamihiraOKinukawaTOnoYOhshimaSOrigasaHTokai Urological Clinical Trial GroupComparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trialBJU Int200596458158616104914
- NishinoYMasueTMiwaKTakahashiYIshiharaSDeguchiTComparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover studyBJU Int200697474775116536766
- GarimellaPSFinkHAMacdonaldRWiltTJNaftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasiaCochrane Database Syst Rev2009CD00736019821408
- NakashimaMKanamaruMUematsuTPhase I clinical study of naftopidil (KT-611), a new alpha1-adrenoceptor blockerJ Clin Therap Med199286381 Japanese
- CollinsKJLow indoor temperatures and morbidity in the elderlyAge Ageing19861542122203751747
- ZhangLEmuraKNakaneYA proposal of optimal floor surface temperature based on survey of literatures related to floor heating environment in JapanAppl Human Sci19981726166
- RoseGSeasonal variation in blood pressure in manNature196118923513743262
- BrennanPJGreenbergGMiallWEThompsonSGSeasonal variation in arterial blood pressureBr Med J (Clin Res Ed)19822856346919923
- YoshimuraKTeraiAFluctuation of night time frequency in patients with symptomatic nocturiaInt J Urol200512546947315948746
- MaSMorilakDAChronic intermittent cold stress sensitises the hypothalamic-pituitary-adrenal response to a novel acute stress by enhancing noradrenergic influence in the rat paraventricular nucleusJ Neuroendocrinol2005171176176916219005
- YamoriYIkedaKKulakowskiECMcCartyRLovenbergWEnhanced sympathetic-adrenal medullary response to cold exposure in spontaneously hypertensive ratsJ Hypertens19853163663998461
- AnderssonKETreatment of the overactive bladder: possible central nervous system drug targetsUrology200259182412007518
- AnderssonKEWeinAJPharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinencePharmacol Rev200456458163115602011
- ImamuraTIshizukaOAizawaNCold environmental stress induces detrusor overactivity via resiniferatoxin-sensitive nerves in conscious ratsNeurourol Urodyn200827434835217701982
- ChenZIshizukaOImamuraTRole of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious ratsNeurourol Urodyn200928325125618837433
- YoshimuraKKamotoTTsukamotoTOshiroKKinukawaNOgawaOSeasonal alterations in nocturia and other storage symptoms in three Japanese communitiesUrology200769586487017482923
- HommaYArakiIIgawaYJapanese Society of Neurogenic BladderClinical guideline for male lower urinary tract symptomsInt J Urol2009161077579019811547
- MadersbacherSAlivizatosGNordlingJSanzCREmbertonMde la RosetteJJEAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines)Eur Urol200446554755415474261
- McVaryKTRoehrbornCGAvinsALUpdate on AUA guideline on the management of benign prostatic hyperplasiaJ Urol201118551793180321420124